Fundz

Onco Myx Therapeutics, Inc. reported raising $50 Million in an initial SEC Form D filing, from an offering of $50 Million

PRIVATEDec 13, 2021

Amount Raised

$50 Million

$50 Million sold, per SEC Form D (first sale Dec 13, 2021)

Round Type

Venture

PhoenixBiotechnology

Quick answer

OncoMyx Therapeutics, Inc. raised $50 Million in a funding round, dated December 13, 2021. OncoMyx Therapeutics, Inc. is based in Phoenix, Arizona, United States.

How much did OncoMyx Therapeutics, Inc. raise?
OncoMyx Therapeutics, Inc. raised $50 Million in a funding round on December 13, 2021.
What does OncoMyx Therapeutics, Inc. do?
OncoMyx Therapeutics is advancing multi-armed, systemic immunotherapies with the potential to be broadly effective in treating solid tumors and heme cancers.
Where is OncoMyx Therapeutics, Inc. based and how big is it?
OncoMyx Therapeutics, Inc. is based in Phoenix, Arizona, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as OncoMyx Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • NextRNA Therapeutics raised $23M on January 27, 2022.
  • Crossfire Medical Inc raised $3M (Seed) on January 27, 2022.
  • Kula Bio raised $50M (Series A) on January 27, 2022.
  • Septerna raised $100M (Series A) on January 27, 2022.
  • Metagenomi Therapeutics, Inc. raised $175M (Series B) on January 26, 2022.
  • Longeviti Neuro Solutions, LLC raised $4.8M (Seed) on January 26, 2022.

Who to call at OncoMyx Therapeutics, Inc., and when

A new round usually means OncoMyx Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day OncoMyx Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at OncoMyx Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at OncoMyx Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

OncoMyx Therapeutics, Inc.

Location

445 N. 5th St.

Phoenix, Arizona, United States

About

OncoMyx Therapeutics is advancing multi-armed, systemic immunotherapies with the potential to be broadly effective in treating solid tumors and heme cancers. Successful immuno-oncology cancer treatment generally requires combination therapy, and OncoMyx’s myxoma platform is designed to deliver multiple cancer-killing payloads in one therapeutic and orchestrate an immune response capable of treating a wide range of cancers. OncoMyx has assembled the top immuno-oncology team to develop next generation immunotherapies that can have the greatest therapeutic benefit for more cancer patients. The company’s myxoma virus platform is poised to be a best-in-class oncolytic virus approach and was developed based on breakthrough research from Dr. Grant McFadden’s lab that was exclusively licensed from Arizona State University. For more information, please visit www.oncomyx.com and connect with the company on LinkedIn and Twitter.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment OncoMyx Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for OncoMyx Therapeutics, Inc.'s next move

See what Strategic adds

OncoMyx Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.